SCHEMBL6409263

SCHEMBL6409263

COC(=O)NC(CCN1CCC2(CC1)CCN(Cc1cccnc1)C2=O)c1cccc(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 3/20 0.49
ROCK1 Q13464 3/20 0.49
MAPT P10636 2/20 0.47
POLB P06746 2/20 0.44
KDM4E B2RXH2 1/20 0.43
GFER P55789 1/20 0.43
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
PKM P14618 1/20 0.40
RAB9A P51151 1/20 0.40
OPRM1 P35372 1/20 0.39
OPRL1 P41146 1/20 0.39
HCRTR2 O43614 1/20 0.39
PTAFR P25105 1/20 0.38
OPRD1 P41143 1/20 0.38
KCNH2 Q12809 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6409256 0.99 ROCK2 (0.48) ROCK2ROCK1MAPTPOLBKDM4E
SCHEMBL6409576 0.94 MAPT (0.52) ROCK2ROCK1MAPTPOLBKDM4E
Hydrochloric Acid SCHEMBL6409569 0.93 MAPT (0.51) ROCK2ROCK1MAPTPOLBKDM4E
SCHEMBL6409365 0.92 MAPT (0.41) ROCK2ROCK1MAPTPOLBKDM4E
Hydrochloric Acid SCHEMBL6417381 0.92 ROCK2 (0.47) ROCK2ROCK1MAPTPOLBKDM4E
Hydrochloric Acid SCHEMBL6409364 0.92 MAPT (0.40) ROCK2ROCK1MAPTPOLBKDM4E
Hydrochloric Acid SCHEMBL6415923 0.91 ROCK2 (0.46) ROCK2ROCK1MAPTPOLBKDM4E
SCHEMBL6414716 0.91 ALDH1A1 (0.44) ROCK2ROCK1MAPTPOLBALDH1A1
Hydrochloric Acid SCHEMBL6414711 0.90 ALDH1A1 (0.43) ROCK2ROCK1MAPTPOLBALDH1A1
SCHEMBL6416494 0.89 MAPT (0.46) ROCK2ROCK1MAPTPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA INC (CA) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity CXCR1, CXCR4, CXCR2 ROCK2 1735/4885ROCK1 1002/4885MAPT 4525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.